Takeda Lays Out Teva JV Impact, Confirms Blopress Transfer

Takeda has identified its first mature products to be transferred next April to a new joint venture with Teva, in a transaction it expects to be cash flow accretive next fiscal year despite an initial hit on revenues and operating profit.